Zhang Investor Law Announces Securities Class Action Lawsuit Against Oasmia Pharmaceutical AB – OASM

NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Oasmia Pharmaceutical AB (NASDAQ: OASM) from October 23, 2015 through July 9, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Oasmia investors under the federal securities laws.

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=oasmia-pharmaceutical-ab&id=1974   or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email [email protected] for information on the class action.

If you wish to serve as lead plaintiff, you must move the Court no later than September 27, 2019.  A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. 

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Oasmia engaged in improper related-party transactions with Alceco International S.A. and Ardenia Investment LTD, which were controlled by Defendant Aleksov and his former father-in-law; (2) due to those transactions, millions of Swedish kronor were not accounted for in Oasmia’s books; (3) transactions concerning Oasmia’s patents were also “carried out in a doubtful way;” and (4) as a result of the aforementioned misconduct, defendants’ statements about Oasmia’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class has not been certified.  You may retain counsel of your choice.  You may take no action at this time and be an absent class member.  Your ability to obtain a recovery is not dependent upon being a lead plaintiff.  

Zhang Investor Law represents investors worldwide.  Attorney Advertising.  Prior results do not guarantee similar outcomes.

Zhang Investor Law P.C.
99 Wall Street, Suite 232
New York, New York 10005
[email protected]
tel: (800) 991-3756